Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution

Introduction Bone metastasis in breast cancer patients can lead to poor quality of life and cause significant morbidity. First-line treatments for bone metastases include bone modifying agents that inhibit osteoclast activity to reduce bone resorption. The most commonly used bone modifying agents in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Briana To, Laura E. Wright, Dureti Doto, Julie Stephans, Marilly Palettas, Kai C. Johnson, Mathew Cherian, Daniel Stover, Ashley Davenport, Margaret Gatti-Mays, Robert Wesolowski, Dionisia Quiroga, Sagar Sardesai, Gilbert Bader, Bhuvaneswari Ramaswamy, Nicole Williams
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	SAGE Publishing 2026-05-01
Saila:	Cancer Control
Sarrera elektronikoa:	https://doi.org/10.1177/10732748261427825
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!